Gelonghui, May 21丨Laikai Pharmaceutical-B (02105.HK) announced that the board of directors has resolved to approve the proposed adoption of the share award plan, subject to shareholders' approval at the annual shareholders' meeting.

The purpose of the share award scheme is to attract and retain participants who have contributed significantly to the long-term growth and success of the Group, recognize and reward their past contributions to the Group, provide participants with an opportunity to obtain the company's exclusive rights and encourage participants to further contribute to the company, and strive to enhance the value of the company and its shares to meet the overall interests of the company and its shareholders. Share award schemes provide companies with flexible methods to retain, motivate, reward, reward, and/or benefit participants.